These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1161970)

  • 1. Platelet monoamine oxidase activity during the course of a schizophreniform psychosis.
    Cookson IB; Owen F; Ridges AP
    Psychol Med; 1975 Aug; 5(3):314-6. PubMed ID: 1161970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM
    Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delusional misidentification and platelet monoamine oxidase.
    Barton JL; Chaparala S; Barton ES; Jackson IV; Davis LG
    Biol Psychiatry; 1980 Apr; 15(2):275-82. PubMed ID: 7417616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
    Mann J; Thomas KM
    Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
    Kemali D; Maj M; Ariano MG; Salvati A
    Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monoamine oxidase activity and schizophrenia.
    Meltzer HY; Arora RC; Babar R; Jackman H; Nasr S; Pscheidt G; Smith M; Strahilevitz M
    Arch Gen Psychiatry; 1980 Mar; 37(3):357. PubMed ID: 7362423
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients.
    Owen F; Bourne R; Crow TJ; Johnstone EC; Bailey AR; Hershon HI
    Arch Gen Psychiatry; 1976 Nov; 33(11):1370-3. PubMed ID: 791182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
    Meltzer HY; Arora RC; Jackman H; Pscheidt G; Smith MD
    Schizophr Bull; 1980; 6(2):213-9. PubMed ID: 7375852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-induced decrease in platelet MAO activity of schizophrenic patients.
    Chojnacki M; Kralik P; Allen RH; Ho BT; Schoolar JC; Smith RC
    Am J Psychiatry; 1981 Jun; 138(6):838-40. PubMed ID: 6113772
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of neuroleptics on platelet monoamine oxidase activity.
    Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
    Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase (MAO) of platelets, plasma, lymphocytes and granulocytes in schizophrenia.
    Bond PA; Cundall RL; Falloon IR
    Br J Psychiatry; 1979 Apr; 134():360-5. PubMed ID: 444786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication.
    Owen F; Bourne RC; Crow TJ; Fadhli AA; Johnstone EC
    Br J Psychiatry; 1981 Jul; 139():16-22. PubMed ID: 7296184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.
    Schildkraut JJ; Herzog JM; Orsulak PJ; Edelman SE; Shein HM; Frazier SH
    Am J Psychiatry; 1976 Apr; 133(4):438-40. PubMed ID: 1267046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet monoamine oxidase activity in schizophrenic patients.
    Becker RE; Shaskan EG
    Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet monoamine oxidase in schizophrenia: a meta-analysis.
    Marcolin MA; Davis JM
    Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet monoamine oxidase activity in acute schizophrenia.
    Carpenter WT; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1975 Apr; 132(4):438-41. PubMed ID: 1119597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting determination of platelet monoamine oxidase activity.
    Jackman HL; Meltzer HY
    Schizophr Bull; 1980; 6(2):259-66. PubMed ID: 6103575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
    DeLisi LE; Wise CD; Bridge TP; Rosenblatt JE; Wagner RL; Morihisa J; Karson C; Potkin SG; Wyatt RJ
    Psychiatry Res; 1981 Feb; 4(1):95-107. PubMed ID: 6111821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.